发明公开
EP3263571A1 CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF
审中-公开
（R）-N-甲基亚甲基四氢溴酸盐的晶体形式及其用途
- 专利标题： CRYSTAL FORM OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF
- 专利标题（中）： （R）-N-甲基亚甲基四氢溴酸盐的晶体形式及其用途
-
申请号： EP17172002.2申请日： 2008-03-28
-
公开(公告)号： EP3263571A1公开(公告)日： 2018-01-03
- 发明人: SMOLENSKAYA, Valeriya, N , AL-SHAREFFI, Kadum A. , PEREZ, Julio , SHAH, Syed M. , BOYD, Thomas
- 申请人： Progenics Pharmaceuticals, Inc. , Wyeth LLC (Formerly Known as Wyeth)
- 申请人地址： 777 Old Saw Mill River Road Tarrytown, NY 10591 US
- 专利权人： Progenics Pharmaceuticals, Inc.,Wyeth LLC (Formerly Known as Wyeth)
- 当前专利权人： Progenics Pharmaceuticals, Inc.,Wyeth LLC (Formerly Known as Wyeth)
- 当前专利权人地址： 777 Old Saw Mill River Road Tarrytown, NY 10591 US
- 代理机构： Russell, Tim
- 优先权： US921111P 20070329
- 主分类号： C07D489/04
- IPC分类号： C07D489/04 ; A61K31/439 ; A61P43/00
摘要：
The present invention provides a new form of (R)-N-methylnaltrexone bromide, and compositions thereof, useful as a peripheral mu opiod receptor antagonist.
公开/授权文献
信息查询
